Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
×
Thyrotropin Alfa
×
Clear all
Filters
2
NCT03244956
2021-09-28
MERAIODE
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
Unknown
40 enrolled